Dáil Éireann Debate, Wednesday - 19 April 2023
139. Deputy John Paul Phelan asked the Minister for Health if he will report on the establishment of a working group on foot of the publication of a report (details supplied) into Ireland's reimbursement process; if he will outline the membership of this group; and if he will make a statement on the matter. [18415/23]
View answerIn February, I published the Mazars Review which examined the governance arrangements around the HSE’s Drug Pricing and Reimbursement Process. I fully support the recommendations contained in the Mazars report around improving the process, increasing transparency, providing easier access, and supporting value for money.
An implementation group has been established between my Department and the HSE to consider and progress the various recommendations contained in the Report as well as other options to improve the process. The Group will engage with stakeholders including patient groups and industry, in seeking to bring about further improvements to the reimbursement process.
The membership of the Group includes representatives of the Drugs Group, the HSE, the NCPE, and the Department of Health.
